Locus is an AI agent that autonomously scouts biotech startups by evaluating their research, patents, and clinical data. The PhD analyst that never sleeps.
The Problem
Your analysts spend weeks reading preprints, cross-referencing patents, and evaluating mechanism-of-action novelty. General VC tools track financials and founder LinkedIn profiles. Nobody reads the biology.
Today's Tools
With Locus
What Locus Does
Continuously scans bioRxiv, medRxiv, and patent databases. Identifies novel research with commercial potential and maps it to startup activity.
Evaluates mechanism-of-action novelty, clinical trial design quality, IP defensibility, and competitive positioning in the therapeutic landscape.
Generates investment-ready deal memos with scientific assessment, market sizing, competitive analysis, and risk evaluation. Ready for your IC meeting.
Monitors your existing portfolio companies for new publications, patent filings, clinical trial updates, and competitive threats. Alerts when action is needed.
Locus exists because the best deals aren't found in databases. They're buried in preprints, patent applications, and clinical trial registries. We read what others can't.